Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Cash Flow-to-Debt Ratio
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥24.79 Million could theoretically repay 0% of its total liabilities (CN¥166.97 Million) in one year. See Shandong Sanyuan Biotechnology Co.Ltd. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Sanyuan Biotechnology Co.Ltd. Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Shandong Sanyuan Biotechnology Co.Ltd. across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shandong Sanyuan Biotechnology Co.Ltd..
Annual Cash Flow-to-Debt Ratio for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
Year-by-year debt coverage analysis for Shandong Sanyuan Biotechnology Co.Ltd.. Check Shandong Sanyuan Biotechnology Co.Ltd. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.04x | CN¥-13.65 Million | CN¥314.04 Million | ▼ -120.7% |
| 2023 | 0.21x | CN¥57.31 Million | CN¥272.40 Million | ▼ -37.8% |
| 2022 | 0.34x | CN¥84.26 Million | CN¥249.14 Million | ▼ -69.0% |
| 2021 | 1.09x | CN¥642.08 Million | CN¥588.83 Million | ▲ +36.2% |
| 2020 | 0.80x | CN¥217.37 Million | CN¥271.48 Million | ▼ -5.8% |
| 2019 | 0.85x | CN¥149.21 Million | CN¥175.59 Million | ▲ +30.0% |
| 2018 | 0.65x | CN¥65.46 Million | CN¥100.12 Million | ▲ +110.9% |
| 2017 | 0.31x | CN¥20.25 Million | CN¥65.31 Million | ▼ -45.4% |
| 2016 | 0.57x | CN¥22.96 Million | CN¥40.44 Million | ▲ +47.3% |
| 2015 | 0.39x | CN¥9.50 Million | CN¥24.64 Million | ▲ +270.0% |
| 2014 | 0.10x | CN¥3.20 Million | CN¥30.68 Million | ▼ -48.8% |
| 2013 | 0.20x | CN¥3.89 Million | CN¥19.10 Million | — |